John Strehl
- Oncology top 5%
- Immunology top 10%
- Pathology and Forensic Medicine top 5%
- Genetics top 5%
- Epidemiology
- Co-authors
- Marcus GorschlüterUlrich MeyCarsten ZiskeAxel GlasmacherIngo G.H. Schmidt‐WolfTilman SauerbruchIngo Schmidt‐WolfChristine Mayr
- Topics
- Immunotherapy and Immune Responses (11 papers)Chronic Lymphocytic Leukemia Research (9 papers)Lymphoma Diagnosis and Treatment (9 papers)
- Journals
- SHILAP Revista de lepidopterologíaBloodThe Lancet Oncology
- Partner nations
- GermanyUnited StatesBelgium
In The Last Decade
John Strehl
32 papers receiving 972 citations
Peers
Comparison fields: 5 of 65
- Oncology 550
- Immunology 327
- Pathology and Forensic Medicine 283
- Genetics 259
- Epidemiology 177
Countries citing papers authored by John Strehl
This map shows the geographic impact of John Strehl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Strehl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Strehl more than expected).
Fields of papers citing papers by John Strehl
This network shows the impact of papers produced by John Strehl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Strehl. The network helps show where John Strehl may publish in the future.
Co-authorship network of co-authors of John Strehl
This figure shows the co-authorship network connecting the top 25 collaborators of John Strehl. A scholar is included among the top collaborators of John Strehl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Strehl. John Strehl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 2 | |
| 3 | High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma | 2 |
| 4 | Minimal size MIDGE vectors improve transgene expression in vivo. | 31 |
| 5 | 24 | |
| 6 | High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma. | 2 |
| 7 | 8 | |
| 8 | 26 | |
| 9 | 42 | |
| 10 | 28 | |
| 11 | 20 | |
| 12 | 54 | |
| 13 | 5 | |
| 14 | 170 | |
| 15 | 5 | |
| 16 | 136 | |
| 17 | 30 | |
| 18 | 2 | |
| 19 | 16 | |
| 20 | 12 |
About John Strehl
John Strehl is a scholar working on Genetics, Immunology and Oncology, having authored 32 papers that have together received 1.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). The work is most often cited by research in Genetics (259 citations), Oncology (550 citations) and Pathology and Forensic Medicine (283 citations). John Strehl has collaborated with scholars based in Germany, United States and Belgium. Frequent co-authors include Marcus Gorschlüter, Ulrich Mey, Carsten Ziske, Axel Glasmacher, Ingo G.H. Schmidt‐Wolf, Tilman Sauerbruch, Ingo Schmidt‐Wolf, Christine Mayr, Michael Schepke and Michael Hallek. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.